Results 1 to 10 of about 286,873 (209)
Intravitreal Dexamethasone Implant in Autoimmune Retinopathy [PDF]
Case Reports in Ophthalmological Medicine, 2023 Purpose. To describe the results of an intravitreal dexamethasone implant in managing autoimmune retinopathy (AIR). Methods. Two patients affected by AIR underwent intravitreal dexamethasone implantation and were followed by ocular coherence tomography ...
Fernando Longhi Bordin +2 more
doaj +5 more sources
Comparative incidence of endophthalmitis after intravitreal dexamethasone implant versus anti-VEGF injections: a retrospective study [PDF]
International Journal of Retina and VitreousBackground Endophthalmitis is a rare but vision-threatening complication of intravitreal injections. Intravitreal dexamethasone implants and anti–vascular endothelial growth factor (anti-VEGF) agents are widely used, yet comparative real-world ...
Iza D. Zabaneh +3 more
doaj +2 more sources
Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy
American Journal of Ophthalmology Case Reports, 2020 Purpose: To report the first case of cystoid macular edema (CME) induced by nabpaclitaxel treated with intravitreal dexamethasone implant. Observations: A 67 year-old man diagnosed with unresectable pancreatic cancer presented with decreased vision in ...
Lorenzo López-Guajardo +2 more
exaly +3 more sources
Revista Brasileira de Oftalmologia, 2021 This report aims to describe the effectiveness of a unilateral intravitreal dexamethasone implant (Ozurdex®) used for the treatment of cystoid macular edema in a patient with recurrent intermediate uveitis.
Bruno Boalento dos Santos +3 more
doaj +2 more sources
The effectiveness of vitrectomy co-adjuvant intravitreal dexamethasone implant on visual outcome in patients with proliferative diabetic retinopathy: study protocol for a prospective randomized controlled trial [PDF]
TrialsBackground Proliferative diabetic retinopathy (PDR) often leads to tractional retinal detachment and vitreous hemorrhage, requiring vitrectomy. Poor visual outcomes are commonly caused by macular edema and proliferative vitreous retinopathy after ...
Jipeng Li +5 more
doaj +2 more sources
An Experience with Intravitreal Dexamethasone Implant for Uveitic Macular Oedema
Journal of Nepal Health Research Council, 2021 Intravitreal steroid implants are the latest trend for uveitis macular oedema treatment. Dexamethasone intravitreal implants are new in our contexts but we report 2 cases of uveitic cystoid macular oedema where this implant proved very useful in the ...
Ranju Kharel (Sitaula) +1 more
doaj +1 more source
The Pan-American Journal of Ophthalmology, 2022 To report the use of intravitreal dexamethasone implant and its short-term efficacy in a pediatric patient with Coats' disease. A 7-year-old patient was referred to the clinic because of decreased visual acuity in the right eye of 10-month duration. Best-
Salcedo Hugo Ricardo +2 more
doaj +1 more source
A case of bilateral cystoid macular edema after rituximab infusion
Indian Journal of Ophthalmology. Case Reports, 2022 A 65-year-old man experienced sudden bilateral vision loss after rituximab infusion. Best corrected visual acuity was 1/10, and cystoid macular edema was identified.
Alexandros Rouvas +2 more
doaj +1 more source
Case Reports in Ophthalmology, 2018 Purpose: We report here the case of a patient with anterior segment migration of intravitreal dexamethasone implant as well as its management and outcome.
Andleeb Zafar +5 more
doaj +1 more source
Oman Journal of Ophthalmology, 2019 The purpose of the study was to report a case of migration of a dexamethasone intravitreal implant (Ozurdex®) into anterior chamber and review the literature pertaining to the anterior chamber migration of implant.
Parthopratim Dutta Majumder +3 more
doaj +1 more source